Central Nervous System Pharmacology Practice Questions

Q: Allergic reactions with amino ester local anesthetics are primarily due to which metabolite?

Para-aminobenzoic acid. **Explanation:** **1. Why Option A is Correct:** Amino ester local anesthetics (e.g., Procaine, Benzocaine, Tetracaine) are metabolized by **plasma pseudocholinesterase** through hydrolysis. This metabolic pathway produces **Para-aminobenzoic acid (PABA)** as a primary byproduct. PABA is a known potent allergen that can trigger Type I (anaphylactic) or Type IV (delayed) hypersensitivity reactions in susceptible individuals. **2. Why Other Options are Incorrect:** * **Option B (Nitrosoamine):** Nitrosoamines are not metabolites of local anesthetics. They are generally associated with dietary sources or tobacco and are known carcinogens, but they play no role in local anesthetic allergy. * **Option C & D:** Since PABA is the specific culprit, these options are incorrect. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Esters vs. Amides:** True allergic reactions are much more common with **Esters** due to PABA. Allergic reactions to **Amides** (Lidocaine, Bupivacaine) are extremely rare. * **Cross-Reactivity:** There is significant cross-reactivity among different ester anesthetics because they all produce PABA. However, there is **no cross-reactivity** between the ester and amide groups. If a patient is allergic to an ester, an amide can usually be safely used. * **Preservatives:** Often, "allergic reactions" attributed to amide anesthetics are actually reactions to the preservative **Methylparaben**, which is chemically similar to PABA. * **Mnemonic:** To distinguish the two classes: Amides have **two "i"s** in their name (L**i**doca**i**ne, Pr**i**loca**i**ne, Bup**i**vaca**i**ne), while Esters have only **one "i"** (Proca**i**ne, Chloroproca**i**ne).

Q: What is the most effective non-habit forming sedative?

Zolpidem. **Explanation:** **Zolpidem** is the correct answer because it belongs to the "Z-drugs" (Non-benzodiazepine hypnotics), which are currently the first-line treatment for short-term insomnia. **Why Zolpidem is correct:** Unlike traditional Benzodiazepines (BZDs), Zolpidem is a selective agonist at the **α1 subunit** of the GABA-A receptor (BZ1 site). This selectivity provides potent sedative and hypnotic effects while lacking significant anticonvulsant, muscle relaxant, or anxiolytic properties. Crucially, Zolpidem has a **lower potential for tolerance, dependence, and "hangover" effects** compared to BZDs, making it the preferred "non-habit forming" option in clinical practice. **Why other options are incorrect:** * **Lorazepam (A) & Flurazepam (C):** These are classic Benzodiazepines. They bind non-selectively to various GABA-A subunits (α1, α2, α3, α5). This lack of selectivity leads to a higher risk of physical dependence, cognitive impairment, and significant withdrawal symptoms upon discontinuation. * **Trazodone (D):** While often used off-label for insomnia due to its sedative side effects (H1 and α1 blockade), it is primarily an antidepressant (SARI). It is not as effective as Zolpidem for sleep induction and is associated with side effects like priapism and orthostatic hypotension. **High-Yield Clinical Pearls for NEET-PG:** * **Antidote:** Flumazenil reverses the effects of both BZDs and Z-drugs (Zolpidem, Zaleplon, Eszopiclone). * **Zaleplon:** Has the shortest half-life among Z-drugs; ideal for sleep-onset insomnia. * **Eszopiclone:** The only Z-drug approved for long-term use (up to 6 months). * **Melatonin Agonist:** Ramelteon is another non-habit forming option, specifically acting on MT1 and MT2 receptors in the suprachiasmatic nucleus.

Q: What is the first-line treatment for trigeminal neuralgia?

Carbamazepine. **Explanation:** **Trigeminal Neuralgia (Tic Douloureux)** is characterized by sudden, severe, brief, stabbing, or shock-like recurrent pain in the distribution of one or more branches of the fifth cranial nerve. **Why Carbamazepine is the Correct Answer:** **Carbamazepine** is the **drug of choice (DOC)** and the first-line treatment for trigeminal neuralgia. It acts by blocking **use-dependent voltage-gated sodium channels**, which stabilizes neuronal membranes and inhibits the repetitive firing of the trigeminal nerve. It provides significant pain relief in approximately 70-80% of patients. **Why Other Options are Incorrect:** * **A. Neurectomy:** This is a destructive surgical procedure involving the cutting of the nerve. It is considered only when medical management fails and less invasive surgical options are exhausted. * **C. Regional nerve block:** While it can provide temporary relief, it is not a first-line or long-term management strategy. * **D. Radiofrequency (Rhizotomy):** This is a minimally invasive surgical option (thermal ablation of the nerve root). It is indicated only for patients who are refractory to medical therapy or cannot tolerate the side effects of drugs. **High-Yield Clinical Pearls for NEET-PG:** * **Second-line drugs:** Oxcarbazepine (often preferred due to fewer side effects), Baclofen, or Lamotrigine. * **Surgical DOC:** **Microvascular Decompression (MVD)**, also known as the Jannetta procedure, is the most effective surgical treatment for cases caused by vascular compression. * **Carbamazepine Side Effects:** Diplopia, ataxia, and most importantly, **Stevens-Johnson Syndrome (SJS)**, especially in patients with the **HLA-B*1502** allele. It is also a potent hepatic enzyme inducer. * **Monitoring:** Periodic CBC is required due to the risk of **agranulocytosis** and aplastic anemia.

Q: Which of the following drugs is NOT used in the prophylactic management of migraine?

Levetiracetam. The prophylactic management of migraine aims to reduce the frequency, severity, and duration of attacks [2]. While several classes of drugs are effective, **Levetiracetam (Option D)** is the correct answer because it has not shown consistent clinical efficacy in migraine prophylaxis and is not recommended by major guidelines (AHS/AAN) [1]. **Why the other options are incorrect (Used in Prophylaxis):** * **Propranolol (Option A):** A non-selective beta-blocker and the **first-line drug** for migraine prophylaxis. It works by modulating central neurotransmitters and preventing vasodilation [2]. * **Flunarizine (Option B):** A non-selective calcium channel blocker with additional H1-blocking properties. It is highly effective in reducing attack frequency, though it may cause weight gain and sedation [2]. * **Topiramate (Option C):** An antiepileptic drug that acts by blocking voltage-gated sodium channels and enhancing GABAergic inhibition [1]. It is a **first-line** prophylactic agent, particularly useful in patients with comorbid obesity (due to weight loss side effects) [2]. **High-Yield Clinical Pearls for NEET-PG:** * **First-line Prophylactic Agents:** Beta-blockers (Propranolol, Timolol), Anticonvulsants (Topiramate, Valproate), and Tricyclic Antidepressants (Amitriptyline) [2]. * **Drug of Choice for Acute Attack:** Sumatriptan (5-HT 1B/1D agonist) [2]. * **Newer Agents:** **CGRP Antagonists** (e.g., Erenumab) are used for refractory cases [2]. * **Contraindication:** Avoid Propranolol in patients with bronchial asthma or peripheral vascular disease. Avoid Valproate in women of childbearing age due to teratogenicity [2].

Q: Methadone is used for opioid withdrawal because it functions as:

An agonist at the opioid receptor. **Explanation:** **1. Why Option C is Correct:** Methadone is a **long-acting synthetic μ (mu) opioid receptor agonist**. In the management of opioid use disorder, it is used for "Opioid Substitution Therapy" (OST). Because it is a full agonist with a long half-life (24–36 hours), it achieves two main goals: * **Prevents Withdrawal:** It stimulates the receptors enough to prevent the physical symptoms of withdrawal. * **Suppresses Craving:** It maintains a steady state in the blood, preventing the "rush" associated with heroin while blocking the cravings. **2. Why Other Options are Incorrect:** * **Option A (Antagonist):** Drugs like **Naloxone** and **Naltrexone** are antagonists. They block the receptor completely. Giving an antagonist to a dependent patient would precipitate immediate, severe withdrawal. * **Option B (Partial Antagonist):** This is not a standard pharmacological classification for opioid therapy. * **Option D (Partial Agonist):** **Buprenorphine** is the classic example of a partial μ-agonist. While it is also used for withdrawal, Methadone is distinct because it is a full agonist. **3. NEET-PG High-Yield Clinical Pearls:** * **NMDA Antagonism:** Apart from being a μ-agonist, Methadone also acts as an **NMDA receptor antagonist**, which may help in treating neuropathic pain and preventing opioid tolerance. * **Side Effect:** A critical "must-know" side effect of Methadone is **QT interval prolongation**, which can lead to Torsades de Pointes. * **Metabolism:** It is primarily metabolized by **CYP3A4**; therefore, inhibitors of this enzyme can lead to methadone toxicity. * **Gold Standard:** Methadone remains the gold standard for opioid maintenance therapy during **pregnancy**.

Q: What is the role of sodium metabisulfite in local anesthetic agents?

Reducing agent. **Explanation:** **Sodium metabisulfite** is added to local anesthetic (LA) solutions specifically when they contain a **vasoconstrictor** (like Adrenaline/Epinephrine). 1. **Why it is a Reducing Agent (Correct Answer):** Adrenaline is highly unstable and prone to oxidation, which turns the solution brown and renders the vasoconstrictor ineffective. Sodium metabisulfite acts as an **antioxidant (reducing agent)**. It has a higher affinity for oxygen than adrenaline; thus, it gets oxidized first, preventing the degradation of the catecholamine and extending the shelf life of the solution. 2. **Analysis of Incorrect Options:** * **Preservative:** While it "preserves" the adrenaline, in pharmacological terms, preservatives refer to antimicrobial agents. Examples in LA include **Methylparaben**, which prevents bacterial growth in multi-dose vials. * **Fungicide:** These are agents that kill fungi. Sodium metabisulfite does not serve this primary purpose in LA solutions. * **Vasoconstrictor:** The vasoconstrictor is the **Adrenaline** itself. Sodium metabisulfite is merely the stabilizer for it. **High-Yield Clinical Pearls for NEET-PG:** * **The "Sulfite" Allergy:** Patients with a history of "sulfite sensitivity" (common in asthmatics) may react to LA solutions containing adrenaline due to the sodium metabisulfite. In such cases, use **plain LA** (e.g., plain Lignocaine). * **pH Alteration:** The addition of sodium metabisulfite makes the LA solution more **acidic** (pH ~3.5–4.5 vs. ~6.5 for plain solutions). This can increase the "sting" on injection and slightly delay the onset of action. * **Methylparaben Warning:** Avoid using LA containing methylparaben for **spinal/epidural** anesthesia, as it is neurotoxic.

Q: Which is a gender-specific adverse effect of valproate?

Polycystic ovary syndrome (PCOS). Explanation:Sodium Valproate is a broad-spectrum antiepileptic drug with a unique side-effect profile. The correct answer is Polycystic Ovary Syndrome (PCOS) because it is the only option listed that is physiologically restricted to females.1. Why PCOS is the correct answer: Valproate is associated with reproductive endocrine dysfunction in women. It can cause hyperandrogenism, menstrual irregularities, and polycystic changes in the ovaries. The mechanism involves valproate-induced weight gain and insulin resistance, which increases androgen production from the theca cells. It may also directly inhibit the conversion of testosterone to estradiol.2. Why other options are incorrect: Weight gain: This is a very common side effect of valproate (due to increased appetite), but it occurs in both males and females. Alopecia: Valproate causes transient hair thinning or curling in about 10% of patients regardless of gender. Hepatotoxicity: This is a serious, idiosyncratic metabolic complication (more common in children <2 years) that affects both genders equally.NEET-PG High-Yield Pearls: Teratogenicity: Valproate is highly teratogenic, specifically causing Neural Tube Defects (e.g., Spina Bifida) due to interference with folate metabolism. Mnemonic for Valproate Side Effects (VALPROATE): Vomiting, Alopecia, Liver toxicity, Pancreatitis/PCOS, Retention of weight (Weight gain), Oedema, Ataxia, Teratogenicity/Thrombocytopenia, Encephalopathy (Hyperammonemia). Drug of Choice: It remains the drug of choice for Myoclonic seizures and Generalized Tonic-Clonic Seizures (GTCS).

Q: All of the following antiepileptic drugs can lead to weight loss except?

Valproate. **Explanation:** The correct answer is **Valproate (Option B)**. In pharmacological management of epilepsy, weight changes are a significant side effect that influences drug selection. **1. Why Valproate is the correct answer:** Valproate is notorious for causing **weight gain**, not weight loss. The mechanism is multifactorial, involving increased appetite, hyperinsulinemia, and metabolic changes. It is often avoided in patients who are already obese or have Polycystic Ovary Syndrome (PCOS), as it can exacerbate weight gain and hormonal imbalances. **2. Analysis of other options (Weight Loss inducing AEDs):** * **Topiramate (Option D):** This is the most potent antiepileptic associated with weight loss. It acts by inhibiting carbonic anhydrase and altering taste perception (making carbonated drinks taste "flat"), leading to reduced caloric intake. It is even FDA-approved in combination with Phentermine for weight loss. * **Zonisamide (Option C):** Similar to Topiramate, it is a sulfonamide derivative that causes significant weight loss and anorexia. * **Felbamate (Option A):** This drug is frequently associated with weight loss and anorexia, though its use is limited due to risks of aplastic anemia and hepatic failure. **High-Yield NEET-PG Pearls:** * **Weight Gain AEDs:** Valproate, Vigabatrin, Gabapentin, Pregabalin, and Carbamazepine. * **Weight Loss AEDs:** Topiramate, Zonisamide, and Felbamate. * **Weight Neutral AEDs:** Levetiracetam, Lamotrigine, and Phenytoin. * **Mnemonic for Topiramate side effects:** **"STOPS"** (Sedation, Stones [Kidney], Thinness [Weight loss], Ocular [Glaucoma], Paresthesia, Speech problems).

Question 1

Allergic reactions with amino ester local anesthetics are primarily due to which metabolite?

Accepted Answer

Para-aminobenzoic acid

Answer

Nitrosoamine

Answer

Both Para-aminobenzoic acid and Nitrosoamine

Answer

Neither Para-aminobenzoic acid nor Nitrosoamine

Question 2

What is the most effective non-habit forming sedative?

Accepted Answer

Zolpidem

Answer

Lorazepam

Answer

Flurazepam

Answer

Trazodone

Question 3

What is the first-line treatment for trigeminal neuralgia?

Accepted Answer

Carbamazepine

Answer

Neurectomy

Answer

Regional nerve block

Answer

Radiofrequency

Question 4

What is the primary mechanism of action of local anesthetics?

Accepted Answer

Inhibition of Na+ channels

Answer

Inhibition of Na+ K+ ATPase

Answer

Inhibition of K+ channels

Answer

Inhibition of Ca2+ channels

Question 5

Which of the following drugs is NOT used in the prophylactic management of migraine?

Accepted Answer

Levetiracetam

Answer

Propranolol

Answer

Flunarizine

Answer

Topiramate

Question 6

Methadone is used for opioid withdrawal because it functions as:

Accepted Answer

An agonist at the opioid receptor

Answer

An antagonist at the opioid receptor

Answer

A partial antagonist at the opioid receptor

Answer

A partial agonist at the opioid receptor

Question 7

Which of the following local anesthetics are not vasodilators?

Accepted Answer

Lignocaine

Answer

Bupivacaine

Answer

Benzocaine

Answer

Tetracaine

Question 8

What is the role of sodium metabisulfite in local anesthetic agents?

Accepted Answer

Reducing agent

Answer

Preservative

Answer

Fungicide

Answer

Vasoconstrictor

Question 9

Which is a gender-specific adverse effect of valproate?

Accepted Answer

Polycystic ovary syndrome (PCOS)

Answer

Weight gain

Answer

Alopecia

Answer

Hepatotoxicity

Question 10

All of the following antiepileptic drugs can lead to weight loss except?

Accepted Answer

Valproate

Answer

Felbamate

Answer

Zonisamide

Answer

Topiramate

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?